Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Prospective, Non-interventional, Multicentre, Controlled Study of Safety and Efficacy of the Thrombolysis With the Non-immunogenic Staphylokinase in Patients With Massive Pulmonary Embolism (FORPE Registry)

NCT07245927 is registered in ClinicalTrials.gov with Supergene, LLC as lead sponsor.

NCT NCT07245927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07245927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Prospective, Non-interventional, Multicentre, Controlled Study of Safety and Efficacy of the Thrombolysis With the Non-immunogenic Staphylokinase in Patients With Massive Pulmonary Embolism (FORPE Registry)
Lead sponsor
Supergene, LLC
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2025
Completion date
December 31, 2027
Enrollment
20,000 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism acute massive